Search
Arrivent Biopharma Inc
AVBPAdd to Watchlist
32.020USD
-1.720-5.10%
Close 06/24, 16:00（ET）Quotes delayed by 15 min
1.49BMarket Cap
LossP/E TTM
Arrivent Biopharma Inc Earnings Date
Period
FY2025 Earnings Date
Revenue(YoY)
--
--
EPS(YoY)
-4.32
-69.06%
Analyst Rating
BUY
2026-06-24
Financial Indicators
EPS
Revenue
Net Profit
Net Margin
Gross Margin
Debt to assets ratio
ROE
ROA
Relevant data have not been disclosed by the company yet.
Income Statement
Revenue
Operating profit
Net Profit
Relevant data have not been disclosed by the company yet.
Balance Sheet
Current assets
Total current liabilities
Total assets
Total liabilities
Total equity
Relevant data have not been disclosed by the company yet.
Cash Flow Statement
Net operating income
Net investment
Net financing
Relevant data have not been disclosed by the company yet.
FAQs
What are the current assets of Arrivent Biopharma Inc?
According to Arrivent Biopharma Inc's FY2025 earnings report, its current assets were 332.90M, with a year-on-year change of 46.66.
What are the total assets of Arrivent Biopharma Inc?
According to Arrivent Biopharma Inc's FY2025 earnings report, its total assets of Arrivent Biopharma Inc were 333.17M, with a year-on-year change of 21.18.
What are the total liabilities of Arrivent Biopharma Inc?
According to Arrivent Biopharma Inc's FY2025 earnings report, its total liabilities of Arrivent Biopharma Inc were 25.95M, with a year-on-year change of 50.08.
What is the total equity of Arrivent Biopharma Inc?
According to Arrivent Biopharma Inc's FY2025 earnings report, its total equity of Arrivent Biopharma Inc was 307.22M, with a year-on-year change of 19.24.
What is the net investment of Arrivent Biopharma Inc?
According to Arrivent Biopharma Inc's FY2025 earnings report, its net investment of Arrivent Biopharma Inc was -71.23M, with a year-on-year change of 62.99.
What is the net financing of Arrivent Biopharma Inc?
According to Arrivent Biopharma Inc's FY2025 earnings report, its net financing of Arrivent Biopharma Inc was 203.06M, with a year-on-year change of 8.83.
What is the Earnings Per Share (EPS) of Arrivent Biopharma Inc?
According to Arrivent Biopharma Inc's FY2025 earnings report, its Earnings Per Share (EPS) was -4.32, with a year-on-year change of -69.06.
What is the Return on Equity (ROE) of Arrivent Biopharma Inc?
According to Arrivent Biopharma Inc's FY2025 earnings report, its Return on Equity (ROE) was -58.88, with a year-on-year change of 61.79.
What is the Return on Assets (ROA) of Arrivent Biopharma Inc?
According to Arrivent Biopharma Inc's FY2025 earnings report, its Return on Assets (ROA) was -54.70, with a year-on-year change of -48.84.
What is the operating profit of Arrivent Biopharma Inc?
According to Arrivent Biopharma Inc's FY2025 earnings report, its operating profit was -177.53M, with a year-on-year change of -88.25.
